SPRB
SPRUCE BIOSCIENCES, INC.
NASDAQ · Healthcare · Biotechnology · US
$53.05
−1.50%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- -$5.68
- Revenue estimate
- $50.0M
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$6.68
- EPS estimate
- -$5.79
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -32.1%
- Revenue beats (12Q)
- 5
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $139
- PT range
- $104 – $160
- Analysts
- 4
4 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$5.79 | -$6.68 | Miss -15.37% | — |
| May 13, 2026 | -$7.32 | -$8.94 | Miss -22.13% | — |
| Aug 14, 2025 | -$18 | -$3.50 | Beat 80.61% | — |
| Apr 15, 2025 | -$0.21 | -$0.57 | Miss -171.43% | $700.0K |
| Mar 26, 2025 | -$0.24 | -$0.57 | Miss -137.88% | $697.0K |
| Mar 13, 2024 | -$0.41 | -$0.23 | Beat 43.90% | $2.9M |
| Nov 13, 2023 | -$0.34 | -$0.30 | Beat 11.76% | $3.1M |
| Aug 14, 2023 | -$0.37 | -$0.32 | Beat 13.51% | $2.2M |
| May 15, 2023 | -$0.42 | -$0.40 | Beat 4.76% | $2.0M |
| Mar 16, 2023 | -$0.55 | -$0.47 | Beat 14.55% | — |
| Nov 10, 2022 | -$0.54 | -$0.48 | Beat 11.11% | — |
| Aug 10, 2022 | -$0.54 | -$0.51 | Beat 5.56% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026